|[October 11, 2013]
Research and Markets: PharmaPoint: Alzheimer's Disease - Italy Research Report
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/5847d2/pharmapoint)
has announced the addition of the "PharmaPoint:
Alzheimer's Disease - Italy Drug Forecast and Market Analysis to 2022"
report to their offering.
PharmaPoint: Alzheimer's Disease - Italy Drug Forecast and Market
Analysis to 2022. There are no long-term effective therapies for
Alzheimer's Disease (AD), so this remains at the top of the list for
unmet needs. While physicians agree that symptomatic therapies are
relatively safe and effective, these therapies are still lacking because
of they cannot maintain their effects and lack mechanisms that alter the
course of the disease
The launch of Arimenda in 2015 will be met with a small sales volume due
to competition from generic products that became available after the
patent expirations of Aricept and Reminyl in 2012. Ebixa is set to lose
its patent protection in 2014, which will allow for a competitive market
for the new entrants that will launch in the middle of the forecast
period: solanezumab, gantenerumab, crenezumab, TRx0237, Lu AE58054, and
MK-8931. Exelon Patch exclusivity will expire in 2019, rounding out the
patent expirations of the currently marketed drugs. EVP-6124 will enter
the market late in the forecast period in 2021.
- Overview of Alzheimer's Disease, including epidemiology, etiology,
symptoms, diagnosis, pathology and treatment guidelines as well as an
overview on the competitive landscape.
- Detailed information on the key drugs in Italy including product
description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in Italy from 2012-2022.
- Analysis of the impact of key events as well the drivers and
restraints affecting Italy Alzheimer's Disease market.
For more information visit http://www.researchandmarkets.com/research/5847d2/pharmapoint
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]